For USA clients a Personal Importation Form based on FDA Chapter 9 guidance for personal importations of drugs will be filed on behalf of the purchaser.

Our affiliated pharmacies are fully licensed in the EU and in strict compliance with FDA regulations for shipping medication for personal use. Solely European Union approved products are provided to you.
* After placing an order for a certain product, you will be asked to complete a medical questionnaire for the medication requested.
* This questionnaire is thoroughly reviewed by one of our licensed physicians.
* Only after your request has been approved by the doctor, your medication will be billed to your credit card.
* An affiliated pharmacy will ship your order by registered mail to the address given by you.
* All shipments are in conformity with FDA guidelines for personal importations and contain a copy of the prescription.

If, for some reason, you do not qualify for the treatment that you are requesting, any advice you receive will be free of charge. Our simple, step by step ordering system makes it easy, safe and affordable to order and receive the medication you need without having to leave the comfort of your home.

Increasing Number Of Immigrant Workers In U.S. Will Have Little Effect On Medicare, Social Security Issues, According To Report
An increasingly aging U.S. population is expected to put additional strain on the costs of government-sponsored programs, such as Social Security and Medicare, even as the rising number of immigrants contributes to the total number of working-age people, according to a study released on Monday by the Pew
Increasing Number Of Immigrant Workers In U.S. Will Have Little Effect On Medicare, Social Security Issues, According To Report...

Kiadis Pharma Announces Successful Completion Of Rhitol(TM) Phase II Clinical Study
Oncology focused biopharmaceutical product development company Kiadis Pharma announced that it has successfully finalized its Rhitol(TM) Phase II clinical trial with the last patient completing its six month treatment cycle. Rhitol(TM) is evaluated as treatment for patients with extensive chronic Graft versus Host Disease (GvHD) intolerant
Kiadis Pharma Announces Successful Completion Of Rhitol(TM) Phase II Clinical Study...